Comparing Treatments in Early-Stage Pediatric Hodgkin Lymphoma
Presently, there is no well-defined standard of care for managing pediatric patients with...
Read MoreMar 19, 2020
Presently, there is no well-defined standard of care for managing pediatric patients with...
Read MoreAug 16, 2012
Recurrent and second primary head-and-neck squamous cell carcinomas (HNSCC) arising within or...
Read MoreMar 20, 2012
The FDA has approved glucarpidase (Voraxaze, BTG International) for treating patients with toxic levels of methotrexate—a type of chemotherapy—in the blood due to kidney failure. The drug breaks down methotrexate to a form that...
Read MoreSep 5, 2011
Colorectal cancer (CRC) is diagnosed in almost 150,000 patients in the United States each year and...
Read MoreSep 21, 2010
A major challenge in treating ovarian cancer is that by the time most patients are diagnosed with...
Read MoreSep 14, 2010
Chemotherapy in the 21st century is only now beginning to evolve from its early, traumatic...
Read MoreAug 10, 2010
Chemotherapy-induced nausea and vomiting (CINV) remains a major adverse effect of cancer...
Read MoreJul 20, 2010
The American Society of Clinical Oncology, or ASCO, held its 2010 annual meeting from June 4 to 8...
Read More